Home Biosimilar Antibodies Others Others Anti-CCL20
For research use only. Not for use in humans.

Anti-CCL20

Synonyms: MIP-3-alpha， LARC

Anti-CCL20 (GSK3050002) is a humanized IgG1κ antibody with high binding affinity to the human chemokine, CCL20. MW:145.5 KD.

Anti-CCL20

Quality Control

Batch: A257201 Purity: 99% Protein concentration: 3.27mg/ml Endotoxin Level: ＜1EU/mg
99

Mechanism of Action

Description
Anti-CCL20 (GSK3050002) is a humanized IgG1κ antibody with high binding affinity to the human chemokine, CCL20. MW:145.5 KD.

Product Details

Molecular Weight 145.5 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT01984047 COMPLETED Drug: GSK3050002|Drug: Placebo Colitis, Ulcerative GlaxoSmithKline 2014-01-10 PHASE1

(data from https://clinicaltrials.gov, updated on 2018-07-24)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.